When doing less adds up to more
"At most companies we've worked with, the people in upstream functions rarely considered the impact their decisions would have on the front line.
"At most companies we've worked with, the people in upstream functions rarely considered the impact their decisions would have on the front line.
The decision to license or sell a drug depends on profitability, strategic mission, and whether a company “believes” in the science of a drug.
“Companies need to modify their search process so that they also look for prototype innovations that users have developed for their own needs."
Legacy graduates (and their families) were seven times as likely to make high-dollar donations as non-legacies.
In their new book, “Power and Progress,” Daron Acemoglu and Simon Johnson ask whether the benefits of AI will be shared widely or feed inequality.
New Venture Advancement Program from MIT Bootcamps uses unique approach of peer-based learning and expert coaching.
The inaugural SERC Symposium convened experts from multiple disciplines to explore the challenges and opportunities that arise with the broad applicability of computing in many aspects of society.
"Companies end up paying a hefty price for low people investment."
"Arm’s partnerships with multinational organisations and overseas expansion to markets like the US helped it become the player it is today."
"It's a travesty that in the richest country in the world, and in the richest period in global history, so many workers are struggling."